Form 8-K - Current report:
SEC Accession No. 0001213900-18-016269
Filing Date
2018-11-20
Accepted
2018-11-20 09:50:58
Documents
3
Period of Report
2018-11-20
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k111518_wizepharma.htm 8-K 18088
2 PRESS RELEASE DATED NOVEMBER 20, 2018 f8k111518ex99-1_wizepharma.htm EX-99.1 16093
3 GRAPHIC ex99-1_001.jpg GRAPHIC 26978
  Complete submission text file 0001213900-18-016269.txt   72750
Mailing Address 5B HANAGAR STREET HOD HASHARON L3 4527708
Business Address 5B HANAGAR STREET HOD HASHARON L3 4527708 972 472 260 0536
Wize Pharma, Inc. (Filer) CIK: 0001218683 (see all company filings)

IRS No.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52545 | Film No.: 181194539
SIC: 2834 Pharmaceutical Preparations